drugset / Trial / NCT03503305

Healing Osteoarthritic Joints in the Wrist With Adult ADRCs

NCT03503305

Active not recruiting 40 enrolled InGeneron, Inc. Sanford Health · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a prospective, randomized, double-blinded, active controlled, single site safety and efficacy study in subjects suffering from chronic wrist osteoarthritis comparing a single ADRC injection generated with the Transpose® RT system into the wrist.

Timeline

Start
2018-11-21
Primary completion
2026-03
Completion
2026-08

Drugs

EvaluationDrugModalityDoseRoute
Subject adipose-derived regenerative cells Cell therapy 5 ml Other

Indications